WHO Drug Information - Volume 37, No. 3

Overview

The third issue of Volume 37, includes

Consultation Documents:

• Albendazole (Albendazolum)
• Albendazole tablets (Albendazoli compressi)
• Albendazole chewable tablets (Albendazoli compressi manducabili)
• Efavirenz (Efavirenzum)
• Ethambutol dihydrochloride (Ethambutoli dihydrochloridum)
• Ethambutol dihydrochloride dispersible tablets (Ethambutoli dihydrochloridi compressi dispersibili)
• Estradiol valerate and norethisterone enantate injection (Estradioli valeras et norethisteroni enantas injectio)
• Molnupiravir (Molnupiravirum)
• Molnupiravir capsules (Molnupiraviri capsulae)
• Nirmatrelvir (Nirmatrelvirum)
• Nirmatrelvir tablets (Nirmatrelviri compressi)
• Tenofovir disoproxil fumarate (Tenofoviri disproxili fumaras)
• WHO guideline on biopharmaceutics classification system-based biowaivers
• Test for diethylene glycol and ethylene glycol in liquid preparations for oral use
• 1.2.1 Melting temperature and melting range
• 2.11 Micro determination of water by the Karl Fischer method
  

The third issue of Volume 37, concludes with:

International Nonproprietary Names (INN) Recommended List No. 90